A microfluidic platform combining endothelialized microchannels and on-chip oxygen control. The devices is used in this work to study hypoxia–reperfusion injury in sickle cell disease and to show that hypoxic preconditioning reduces vaso-occlusion.
Schad et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: